{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:20:13Z","timestamp":1778617213417,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bmcl.2019.126906","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T02:37:53Z","timestamp":1577327873000},"page":"126906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors"],"prefix":"10.1016","volume":"30","author":[{"given":"Yixuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanni","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingpeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5771-0252","authenticated-orcid":false,"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.126906_b0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.bmcl.2019.126906_b0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0035-9203(54)90006-1","article-title":"Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria","volume":"48","author":"Macnamara","year":"1954","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.bmcl.2019.126906_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002636","article-title":"Molecular evolution of Zika virus during its emergence in the 20th century","volume":"8","author":"Faye","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmcl.2019.126906_b0020","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bmcl.2019.126906_b0025","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3201\/eid2110.151125","article-title":"Zika virus transmission from French Polynesia to Brazil","volume":"21","author":"Musso","year":"2015","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.bmcl.2019.126906_b0030","unstructured":"World Health Organization. ZIKA EPIDEMIOLOGY UPDATE July 2019. Accessible at: https:\/\/www.who.int\/emergencies\/diseases\/zika\/zika-epidemiology-update-july-2019.pdf?ua=1; Accessed 2 July 2019."},{"key":"10.1016\/j.bmcl.2019.126906_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1605367","article-title":"Zika and the risk of microcephaly","volume":"375","author":"Johansson","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bmcl.2019.126906_b0040","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika Virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.bmcl.2019.126906_b0045","doi-asserted-by":"crossref","unstructured":"Durbin A1, Wilder-Smith A. An update on Zika vaccine developments. Expert Rev Vaccines. 2017; 16: 781\u2013787.","DOI":"10.1080\/14760584.2017.1345309"},{"key":"10.1016\/j.bmcl.2019.126906_b0050","first-page":"ofw175","article-title":"Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus. Open Forum","volume":"3","author":"Deng","year":"2016","journal-title":"Infect Dis."},{"key":"10.1016\/j.bmcl.2019.126906_b0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","article-title":"Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model","volume":"137","author":"Julander","year":"2017","journal-title":"Antivir Res."},{"key":"10.1016\/j.bmcl.2019.126906_b0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aag2419","article-title":"Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor","volume":"353","author":"Lei","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2019.126906_b0065","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jacs.9b02505","article-title":"Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease","volume":"141","author":"Yao","year":"2019","journal-title":"J Am Chem Soc."},{"key":"10.1016\/j.bmcl.2019.126906_b0070","doi-asserted-by":"crossref","unstructured":"Yuan S, Chan JF, den-Haan H, Chik KK, Zhang AJ, Chan CC, Poon VK, Yip CC, Mak WW, Zhu Z, Zou Z, Tee KM, Cai JP, Chan KH, de la Pe\u00f1a J, P\u00e9rez-S\u00e1nchez H, Cer\u00f3n-Carrasco JP, Yuen KY. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo. Antivir Res. 2017; 145: 33\u201343.","DOI":"10.1016\/j.antiviral.2017.07.007"},{"key":"10.1016\/j.bmcl.2019.126906_b0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Bullard-Feibelman","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bmcl.2019.126906_b0080","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00705-017-3345-x","article-title":"Structural basis of Zika virus methyltransferase inhibition by sinefungin","volume":"162","author":"Hercik","year":"2017","journal-title":"Arch Virol."},{"key":"10.1016\/j.bmcl.2019.126906_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2017.11.004","article-title":"Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens","volume":"149","author":"Tong","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bmcl.2019.126906_b0090","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat Med."},{"key":"10.1016\/j.bmcl.2019.126906_b0095","doi-asserted-by":"crossref","first-page":"E322","DOI":"10.3390\/v8120322","article-title":"Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models","volume":"8","author":"Delvecchio","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2019.126906_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2016.11.018","article-title":"Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay","volume":"138","author":"Adcock","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bmcl.2019.126906_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004695","article-title":"The viral polymerase inhibitor 7-Deaza-2'-C-Methyladenosine Is a potent inhibitor of in vitro zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Zmurko","year":"2016","journal-title":"PLoS Negl Trop Dis."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19308844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19308844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:33:50Z","timestamp":1760772830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19308844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0960894X19308844"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126906","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"126906"}}